Gynecologic Cancer
Specialty Channel

Featured Article
Experts determine the Role of CD10 expression in endometriosis-associated mesenchymal stem cells on the progression of endometriosis-associated carcinoma, presented at the 2021 ASCO Annual Meeting.
True or False: Study findings presented at the 2021 ASCO Annual Meeting support the use of frequent routine imaging and laboratory exams in patients treated for endometrial cancer.
Quiz: Among young adult women in the United States, the number of endometrial cancer cases has risen alongside rates of which of the following conditions?
The use of upfront multi-gene panel testing (MGPT) in patients with endometrial cancer has improved the detection of Lynch syndrome among this population.
According to study findings presented at the 2021 ASCO Annual Meeting, the use of frequent routine imaging and laboratory exams in patients treated for endometrial cancer should be discouraged.
The FDA has approved dostarlimab-gxly for the treatment of adults with dMMR recurrent or advanced endometrial cancer that progressed during or after a platinum-containing therapy.
Post-operative systemic chemo and RT did not improve OS in high-risk patients with stage I endometrial cancer, according to Rachelle Findley, MD, et al.
Findings from a study presented at the 2021 SGO Virtual Annual Meeting on Women's Cancer, frail patients with ovarian cancer who undergo surgery at institutions with higher surgical volume have lower…
In a session presented at the 2021 SGO Annual Meeting on Women’s Cancer Rebecca Kristeleit, PhD, UCL Cancer Institute, London, shared findings from the ARIEL4 study on rucaparib versus chemotherapy.

News

Experts determine the Role of CD10 expression in endometriosis-associated mesenchymal stem cells on the progression of endometriosis-associated carcinoma, presented at the 2021 ASCO Annual Meeting.
The use of upfront multi-gene panel testing (MGPT) in patients with endometrial cancer has improved the detection of Lynch syndrome among this population.
According to study findings presented at the 2021 ASCO Annual Meeting, the use of frequent routine imaging and laboratory exams in patients treated for endometrial cancer should be discouraged.
The FDA has approved dostarlimab-gxly for the treatment of adults with dMMR recurrent or advanced endometrial cancer that progressed during or after a platinum-containing therapy.

Interactive Features

True or False: Study findings presented at the 2021 ASCO Annual Meeting support the use of frequent routine imaging and laboratory exams in patients treated for endometrial cancer.
Quiz: Among young adult women in the United States, the number of endometrial cancer cases has risen alongside rates of which of the following conditions?
According to the ARIEL3 study, _______ extended PFS for ovarian cancer despite toxicities?
True or False: Pembrolizumab provided a durable clinical response in cisplatin-ineligible patients with advanced urothelial carcinoma and is associated with prolonged OS.
Stay in the know.
OncNet Newsletter